Articles On Volpara Health Technologies (ASX:VHT)

Volpara Health Technologies Ltd (ASX: VHT) today announced it is on track to meet its upgraded annual recurring revenue guidance of NZ$17.8 million, subject to one or two major deals closing. At the time of writing, the Volpara share price...

If you’re looking for a little exposure to the small cap side of the market, then you’re in luck. At present there are a good number of small cap shares that I believe have enormous potential. While not all small caps will live up to their...

Last year the ASX’s biotechs began kicking goals they’d promised years ago, as small caps from eye disease curer Opthea (ASX:OPT) to breast density imager Volpara (ASX:VHT) launched their way into the collective consciousness. The biotechs...

If you’re interested in small cap shares, then you are in luck. Because right now there are a good number trading on the ASX which I think have a lot of potential. Three which I think would be worth keeping a very close eye on this year ar...

Analysts from financial services firm Taylor Collison recently released a report that reiterated their buy rating on Mach7 Technologies Ltd (ASX: M7T). Here’s why analysts think this ASX tech stock is poised to rocket in 2020 and beyond. W...

With reporting season about to commence amid the bush fires and coronavirus, the environment is ripe for more positive and negative surprises than we have seen in some time. Meanwhile the ASX 200 industrial index, excluding financials, is t...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 1.35% to ...

The Volpara Health Technologies Ltd (ASX: VHT) share price was trading as much as 4% higher today. For comparison, the S&P/ASX 200 (INDEXASX: XJO) closed the day 1.35% lower. Here’s why Volpara bucked the trend. About Volpara Health Tec...

Medical technology company Volpara (VHT) has experienced another strong quarter of growth Cash receipts for the quarter were $4.35 million, which is up 138 per cent from the same period last year This reflects last year’s purchase of MRS...

Quarterly reports for biotechs usually only tell investors how much cash they have left — and how much time they have until the next cap raise. But December quarterlies from late Friday and today include several companies that are making mo...

Earlier today I looked at how successful small cap investing can be if you can identify a start of the future. With that in mind, I thought I would pick out several small cap shares which I believe have significant potential and could gene...

Since Xero (ASX:XRO) listed on the ASX in 2012, it has risen from less than $5 to over $84 today – a gain of 1,700 per cent. But did you know Xero’s listed life began on the New Zealand Exchange (NZX)? The accounting software giant first we...

Although the Pro Medicus Limited (ASX: PME) share price is down materially from its 52-week high, it is still up significantly over the last 12 months. Since this time last year, the medical imaging software company’s shares are up a massi...

I think that one of the best ways to make market-beating returns is to have a little exposure to the small cap side of the market. After all, it wasn’t that long ago that Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX) were classed as s...

The Volpara Health Technologies Ltd (ASX: VHT) share price has been a great performer for investors. Volpara shares are currently up 49% over the last 12 months and 276% since the company’s IPO back in April 2016. Volpara is a medical tec...

Yesterday, Stockhead reviewed the small caps that are devising treatments to fight cancer. There are also a handful of small caps that are seeking to help with diagnostics. In other words these small caps are either seeking to identify the...

The European Commission has granted Orphan drug status for Alterity Therapeutics’ (ASX:ATH) lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA). That gives Alterity 10 years of market exclusivity in the European Union...

In 2019 the culmination of decades worth of work turned several biotechs and life sciences companies into overnight successes. As investors look to defensive growth stocks to compensate for a sluggish economy and with expectations of more h...

If your risk profile allows for it, I think having a little exposure to the small side of the market can do wonders for a portfolio. After all, the potential returns on offer at this side of the market are significant. Though, it is worth...

I think the Australian share market is home to a large number of small cap shares that have the potential to grow materially larger in the future. While history shows that not all small caps deliver on their potential, I think many of thes...

Australian health care sector is one of the fastest growing, dynamic and highly diversified sectors having enormous potential to generate substantial returns for the Australian economy. A broad range of companies, from companies engaged in...

Pro Medicus Limited (ASX: PME) shares are up. 2.8 per cent to $22.34 in morning trade after the medical software provider updated the market on its performance for the half year ending December 31 2019.  The company is eager to emphasise t...

I think the ASX is home to a good number of small cap shares that have the potential to grow notably larger in the future. While history shows that not all small caps will ultimately deliver on their potential, I think many of these shares...

Australian health care sector is booming with strong growth prospects amid global trade worries and market volatility. Being dynamic and lucrative sector, it catches investors’ attention often. When the share price of a company is multiplie...

If you’re a fan of investing in small cap shares, then you’re in luck. Right now, I believe there are a large number of quality options at the small end of town. Five standouts are listed below. Here’s why I think these ASX small cap share...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

In the Australian health care system, three levels of government are responsible for providing universal health care- federal government, state and territory government and local government. Funding and indirect support are provided by the...

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction of technologies in the health care domain emerged as the biggest blessing not only for pa...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Thursday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.23%...

In afternoon trade the S&P/ASX 200 index is on course to record yet another gain. At the time of writing the benchmark index is up 0.25% to 6,867 points. Four shares that are climbing more than most today are listed below. Here’s why t...

The Volpara Health Technologies Ltd (ASX: VHT) share price has been a strong performer today. In afternoon trade the healthcare technology company’s shares are up almost 4% to $1.87. Why is the Volpara share price racing higher? Investors...

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with executive director and CEO of Volpar...

The S&P/ASX 200 index is on course to continue its positive run on Tuesday. In afternoon trade the benchmark index is up a solid 0.8% to 6,783 points. Four shares that have failed to follow the market higher today are listed below. Her...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

One of the most attractive features about a potential investment can be its recurring revenue. If you can see that a business will retain most of its revenue year after year (and grow with new revenue) then it’s easier to get your head aro...

The S&P/ASX 200 index has given back yesterday’s gains and dropped sharply lower. The benchmark index is down 1.3% to 6,725 points in afternoon trade. Four shares that have fallen more than most are listed below. Here’s why they are tu...

The ALS Ltd (ASX: ALQ) share price is pushing higher in morning trade after the release of a better than expected first half result. At the time of writing the testing services company’s shares are up 2% to $8.21. How did ALS perform in th...

The Volpara Health Technologies (ASX: VHT) share price will be on watch this morning after reporting its half year result. Volpara describes itself as a ‘MedTech Software as a Service’ company that was founded in 2009 on research conducted...

The Volpara Health Technologies Ltd (ASX: VHT) share price will be on watch today following the release of its half year results. How did Volpara perform in the first half? For the six months ended September 30, Volpara reported total reve...

Got 90 seconds? Then listen to executive director and CEO of Volpara Health Technologies Ralph Highnam tell us more about the company and its upcoming news flow. Volpara provides breast imaging analytics and analysis products to improve cli...

In the share market risk and return are positively correlated as the more risk you take, the higher the potential return.  Small cap shares can provide investors huge returns, but the catch is that for every big winner there are dozens of...

Health care sector in Australia is growing tremendously, as there is always the requirement of developing new therapies or treatments for the diseases which are chronic and rare or for the unmet medical needs. The Australian health care ind...

The Advance Nanotek Ltd (ASX: ANO) share price has been amongst the best performers on the market on Friday. In afternoon trade the advanced materials company’s shares were up over 8% to $6.32. This latest gain means its shares are up a ma...

If your risk profile allows for it, I think a little exposure to the small cap side of the market can be a good thing for a portfolio. After all, the likes of Afterpay Touch Group Ltd (ASX: APT) and Ramsay Health Care Limited (ASX: RHC) we...

The ASX200 is potentially witnessing a transition from growth to value shares. This has seen household names such as Afterpay Touch Group Ltd (ASX: APT), Appen Ltd (ASX: APX) and Altium Limited (ASX: ALU) and more, down by more than 20%. H...

I think that having a little exposure to the small cap side of the market can be a good thing for a portfolio if your risk profile allows for it. After all, the potential returns on offer with small caps are vastly superior to those of the...

ASX small caps are the ones that could become the next Xero Limited (ASX: XRO) or A2 Milk Company Ltd (ASX: A2M). All the current big businesses like CSL Limited (ASX: CSL) and Transurban Group (ASX: TCL) were small companies at once stage...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

The ‘software as a service’ (SAAS) business model has taken off in the computer software sector over the past few years. Now, the same concept is gaining traction in medtech. Take Volpara Health Technologies (ASX:VHT), a breast imaging soft...

Nowadays, technology plays a significant role in each sector of the industry. Introduction of information technology into the health care industry has created a revolution by helping in the detection and diagnosis of chronic diseases prompt...